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Corynebacterium diphtheriae is a noncapsulated, club-shaped facultative 46 
anaerobic Gram-positive bacilli. Opportunistic or cutaneous co-infection caused by 47 
this microorganism, especially non-toxigenic strains, has become important in 48 
travellers [1]. The skin lesions are generally ulcerative with a torpid and nonspecific 49 
evolution, which usually appear after a bite or minor trauma [2]. These infections 50 
have a low incidence [3], which is why this microorganism is often not considered as 51 
the first etiological diagnosis, so in many of the cases can be unnoticed. A study of 52 
two cases of infection by C. diphtheriae and Streptococcus pyogenes was 53 
performed. The microorganisms were isolated from swabs of wound exudates and 54 
were identified by mass spectrometry (MALDI-TOF MS, Bruker©) and were 55 
confirmed with the amplification and sequencing of the 16S rRNA gene. Diphtheria 56 
toxin was performed by PCR [4] . 57 
 58 
Case 1 59 
A 28-year-old man with a recent travel history to Philippines attended for an 60 
incised wound on the back of the left foot of 15 days of evolution, with signs of 61 
cellulitis. The case was oriented as cellulitis and started intravenous treatment with 62 
ceftriaxone 1g for 5 days and linezolid 600 mg for 3 days, after that the treatment 63 
were change to oral azithromycin for one week. In culture, S. pyogenes and 64 
C.diphtheriae were isolated. Antibiotic susceptibility testing (AST) was performed 65 
and both microorganisms were susceptible to penicillin and erythromycin. Diphtheria 66 
toxin was negative. The patients evolving favourably and subsequently decided to 67 
administer a booster of diphtheria vaccine. 68 
Case 2 69 
A 32-year-old man, with a recent travel history to Southeast Asia for 2 70 
months. Attended for a traumatic wound in the heel and erythematous and crusted 71 
lesions of 2-3 cm in the right leg. Physical examination reveals a peripheral pustule 72 
with inflammation of an inguinal node without signs of cellulitis in the peripheral skin. 73 
The case was oriented as skin infection by biting of overinfected arthropods. 74 
Serology was requested for Dengue, Chikungunya and culture. S. pyogenes and 75 
C.diphtheriae were isolated. AST was performed and both microorganisms were 76 
susceptible to penicillin and erythromycin. Serologies for Dengue and Chikungunya 77 
were negative. Treatment with oral erythromycin 500 mg every six hour for 14 days 78 
was started, contact study was carried out and reinforcement of the diphtheria 79 
vaccine was administered. Diphtheria toxin was negative; the patient was evaluated 80 
for 2 weeks, showing resolution of both traumatic wound and satellite lesions. 81 
Cutaneous infection by C. diphtheriae is uncommon, tends to be of torpid 82 
evolution   and produce nonspecific lesions, so clinical suspicion is low. In recent 83 
years this infection has been linked mainly with travellers to endemic areas including 84 
Southeast Asia, some countries such as Cambodia, India, Indonesia, Malaysia, New 85 
Guinea, Philippines, Thailand, Brazil and others [5] [6]. A study in Vancouver reports 86 
37 cases of cutaneous diphtheria for non-toxigenic strains [8] which demonstrates 87 
the high distribution of these strains. In Europe, the data was based mainly on 88 
patients with a recent travel history [7], except in some Eastern European countries, 89 
which are considered an endemics areas [2]. 90 
 Other risk factors for the infection included  population with low 91 
socioeconomic resources, alcohol abuse, drugs, HIV infection, hepatitis, cirrhosis, 92 
[8] [3]. Identification of Gram positive bacilli colonies may be considered in some 93 
cases as non-pathogenic microbiota by the genus of Corynebacterium, and 94 
presence of C.diphtheriae may be misidentified. In these cases we can apply the 95 
MALDI-TOF MS, it’s an easy  technique and effective cost [2]. 96 
 97 
Co-infection is a common clinical presentation. S. pyogenes, Staphylococcus 98 
aureus, methicillin-resistant S. aureus, Arcanobacterium haemolyticum and species 99 
of coagulase-negative staphylococci [8] are the more frequently association. In 2016 100 
a third case of cutaneous diphtheria was also reported  where colonies of A. 101 
haemolyticum were also isolated in a 50-year-old patient with a recent travel history 102 
to Guinea Bissau and mimicking pyoderma gangrenosum [9].  103 
 104 
 Benzylpenicillin and macrolides were considered first line treatment in cases 105 
of diphtheria, but in 2015 the first case of C. diphtheriae resistant to penicillin was 106 
published in a cutaneous infection by a non-toxigenic strain in the United Kingdom 107 
[10] However, benzylpenicilin continue to be the first option for treatment in case of 108 
diphtheria. In our cases the both strains and both S.pyogenes were susceptible to 109 
penicillin and erythromycin. In Spain in 2015, the first case of diphtheria was 110 
reported since 1986, in a 6-year-old unvaccinated child, who progressed 111 
unfavourably and died after one month of medical treatment. However, in relation to 112 
cutaneous diphtheria, no previous reports have been found.  113 
The number of travellers continues to increase in Spain and Europe, which 114 
can increase the incidence of these mixed infections. The recent travel history 115 
should be recognized as an epidemiological data to highlight not only the clinical 116 
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